SCHEMBL3358460

SCHEMBL3358460

CON(C)C(=O)C=Cc1cncc(OCc2ccccc2)c1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APP P05067 5/20 0.60
ALDH1A1 P00352 2/20 0.51
KDM4E B2RXH2 1/20 0.51
PKM P14618 1/20 0.51
LMNA P02545 1/20 0.48
THRB P10828 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
GSK3B P49841 5/20 0.47
BACE1 P56817 3/20 0.47
MAOB P27338 1/20 0.46
SIRT2 Q8IXJ6 1/20 0.46
SIRT1 Q96EB6 1/20 0.46
SIRT3 Q9NTG7 1/20 0.46
AKT1 P31749 2/20 0.44
ROCK2 O75116 1/20 0.44
RPS6KA5 O75582 1/20 0.44
MAP4K4 O95819 1/20 0.44
PIM1 P11309 1/20 0.44
PRKACA P17612 1/20 0.44
RPS6KB1 P23443 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3358456 1.00 APP (0.60) APPALDH1A1KDM4EPKMLMNA
SCHEMBL1532718 0.86 KDM4E (0.55) APPALDH1A1KDM4EPKMLMNA
SCHEMBL2187050 0.85 ALDH1A1 (0.69) ALDH1A1KDM4EPKMLMNATHRB
SCHEMBL2187055 0.85 ALDH1A1 (0.69) ALDH1A1KDM4EPKMLMNATHRB
SCHEMBL13308164 0.83 ALDH1A1 (0.55) ALDH1A1KDM4EPKMLMNATHRB
SCHEMBL6136949 0.81 LMNA (0.51) ALDH1A1KDM4EPKMLMNATHRB
SCHEMBL6136951 0.81 LMNA (0.51) ALDH1A1KDM4EPKMLMNATHRB
SCHEMBL20103340 0.80 KMT2A (0.49) MAOBSIRT2SIRT1SIRT3
SCHEMBL7924857 0.80 AKT1 (0.42) APPAKT1ROCK2RPS6KA5MAP4K4
SCHEMBL2187265 0.78 EGFR (0.49) APPALDH1A1KDM4EPKMLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130184313-A1 NICOTINIC ACETYLCHOLINE RECEPTOR LIGANDS AND THE USES THEREOF THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) 2013-07-18 US disclosed
US-8445684-B2 Nicotinic acetylcholine receptor ligands and the uses thereof PsycoGenics Inc. (US) 2013-05-21 US disclosed
US-20100152450-A1 NICOTINIC ACETYLCHOLINE RECEPTOR LIGANDS AND THE USES THEREOF PSYCHOGENICS, INC. (US) 2010-06-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100152450-A1 NICOTINIC ACETYLCHOLINE RECEPTOR LIGANDS AND THE USES THEREOF CHRNG, CHRNA5, CHRNA2 APP 1176/4885ALDH1A1 1052/4885KDM4E 2600/4885
US-20130184313-A1 NICOTINIC ACETYLCHOLINE RECEPTOR LIGANDS AND THE USES THEREOF CHRNG, CHRNA5, CHRNA2 APP 1176/4885ALDH1A1 1052/4885KDM4E 2600/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.